Insider Transactions in Q4 2024 at Cvs Health Corp (CVS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2024
|
Anne A. Finucane Director |
SELL
Bona fide gift
|
Direct |
2,665
-36.85%
|
$149,240
$56.86 P/Share
|
|
Nov 30
2024
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-1.01%
|
$5,074
$59.85 P/Share
|
|
Nov 30
2024
|
Heidi B Capozzi EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,542
+50.0%
|
$4,928,978
$59.85 P/Share
|
|
Nov 30
2024
|
Roger N Farah Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,125
+50.0%
|
$2,957,375
$59.85 P/Share
|
|
Nov 30
2024
|
Tilak Mandadi EVP, Chief DDAT Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,125
+33.45%
|
$2,957,375
$59.85 P/Share
|
|
Nov 21
2024
|
Guy P Sansone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+20.83%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Douglas H. Shulman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+50.0%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+50.0%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+32.77%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,331
+6.39%
|
$132,867
$57.1 P/Share
|
|
Nov 21
2024
|
J Scott Kirby Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,933
+25.51%
|
$167,181
$57.1 P/Share
|
|
Nov 21
2024
|
Michael F Mahoney Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+26.19%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+6.02%
|
$134,748
$57.1 P/Share
|
|
Nov 21
2024
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,375
+19.75%
|
$135,375
$57.1 P/Share
|
|
Nov 21
2024
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,331
+1.85%
|
$132,867
$57.1 P/Share
|